Shandong Weigao Blood Purification Products Co (SHSE:603014) Beginning Cash Position: ¥1,377 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603014 Shandong Weigao Blood Purification Products Co Ltd SHSE:603014
39 GF Score
Price ¥31.47
! 3 Warning Signs
View Full Analysis

What is Shandong Weigao Blood Purification Products Co Beginning Cash Position?

Shandong Weigao Blood Purification Products Co SHSE:603014 +0.77% 39 Beginning Cash Position is ¥1,377 Mil as of Jun. 2026. GuruFocus rates SHSE:603014 with a GF Score™ of 39/100. The stock has 3 warning signs investors should review.

Shandong Weigao Blood Purification Products Co's Beginning Cash Position for the quarter that ended in Jun. 2026 was ¥1,377 Mil.

Shandong Weigao Blood Purification Products Co's quarterly Beginning Cash Position declined from Dec. 2025 (¥2,076 Mil) to Mar. 2026 (¥1,504 Mil) and declined from Mar. 2026 (¥1,504 Mil) to Jun. 2026 (¥1,377 Mil).

Shandong Weigao Blood Purification Products Co's annual Beginning Cash Position increased from Dec. 2023 (¥592 Mil) to Dec. 2024 (¥641 Mil) and increased from Dec. 2024 (¥641 Mil) to Dec. 2025 (¥1,239 Mil).

Shandong Weigao Blood Purification Products Co Beginning Cash Position Related Terms

Shandong Weigao Blood Purification Products Co Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Shandong Weigao Blood Purification Products Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Weigao Blood Purification Products Co Beginning Cash Position Chart

Shandong Weigao Blood Purification Products Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial 453.25 322.52 591.97 641.07 1,238.92

Shandong Weigao Blood Purification Products Co Quarterly Data
Sep24 Mar25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial - 1,634.78 2,075.69 1,503.98 1,376.52
SHSE:603014
39GF Score
Shandong Weigao Blood Purification Products Co Ltd SHSE:603014
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Weigao Blood Purification Products Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of ¥1,377 Mil mean?
Shandong Weigao Blood Purification Products Co (SHSE:603014) has a Beginning Cash Position of ¥1,377 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Shandong Weigao Blood Purification Products Co and its competitors.
Is Shandong Weigao Blood Purification Products Co's Beginning Cash Position too high?
Shandong Weigao Blood Purification Products Co's current Beginning Cash Position is ¥1,377 Mil. Overall, Shandong Weigao Blood Purification Products Co has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Blood Purification Products Co's Beginning Cash Position compare to ABT and SYK?
Shandong Weigao Blood Purification Products Co's Beginning Cash Position of ¥1,377 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Shandong Weigao Blood Purification Products Co and its competitors. Shandong Weigao Blood Purification Products Co's current Beginning Cash Position is ¥1,377 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Blood Purification Products Co stock overvalued right now?
Shandong Weigao Blood Purification Products Co (SHSE:603014) has a current Beginning Cash Position of ¥1,377 Mil. The current Beginning Cash Position is ¥1,377 Mil. Shandong Weigao Blood Purification Products Co's overall GF Score™ is 39/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Shandong Weigao Blood Purification Products Co (SHSE:603014), the current Beginning Cash Position is ¥1,377 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shandong Weigao Blood Purification Products Co Business Description

Address No. 7, Weigao West Road, Torch High-tech Industrial Development Zone, Shandong Province, Weihai, CHN, 264200
Shandong Weigao Blood Purification Products Co Ltd engaged in research and development, production and sales of blood purification medical products.
39GF Score

Get the complete analysis for SHSE:603014

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥31.47
Price